Moody's assigns 'Baa2' rating to Boston Medical Center's bonds

Moody's Investors Service has assigned a "Baa2" rating to Boston Medical Center's proposed $180 million of series 2016E revenue bonds.

The rating assignment is based on several factors, including Boston Medical Center's key role as a healthcare provider in the area and as a provider of health insurance services through an affiliated insurance plan.

BMC also faces challenges, including a payer mix heavily weighted toward governmental payers.

The outlook is stable, reflecting Moody's Investors Services' view that BMC will continue to receive supplemental funding and generate adequate margins.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars